In comparison, from January 2014 to December 2021, the HER2 French database, a platform collecting data on different tumors from all French comprehensive cancer centers, registered 19.3% of HER2 score 1 + and 24.0% of HER2 score 2 + tumors before NAC [33]. Here, ERBB2 is linked to cancer.